Teva Pharmaceutical Industries Ltd. (TEVA) vs United Therapeutics Corporation (UTHR)
- Teva Pharmaceutical Industries Ltd. TEVA 41.52 +1.00%
- United Therapeutics Corporation UTHR 533.12 −1.55%
Teva Pharmaceutical Industries Ltd. and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $47.9B against $23.2B — 2.1× the size. United Therapeutics Corporation trades at the lower P/E: 17.6× against 65.9×. Teva Pharmaceutical Industries Ltd. grew revenue faster over the last twelve months: 4.13% against 2.49%. United Therapeutics Corporation has the higher net margin (41.6% vs 4.08%) and the higher return on invested capital (23.4% vs 4.58%). Across the 22 metrics below, United Therapeutics Corporation leads on 18 and Teva Pharmaceutical Industries Ltd. on 4.
Valuation
Profitability
| Metric | TEVA | UTHR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 52.46% | 86.14% | 53.94% |
| Operating margin | 8.77% | 44.44% | 0.00% |
| Net margin | 4.08% | 41.56% | 0.00% |
| Free cash flow margin | 8.09% | 34.65% | 0.00% |
| Return on equity | 9.69% | 19.32% | (0.40%) |
| Return on assets | 1.77% | 17.33% | (3.32%) |
| Return on invested capital | 4.58% | 23.44% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack